TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 199 filers reported holding TG THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $97,168 | -66.3% | 11,623 | 0.0% | 0.02% | -66.2% |
| Q2 2023 | $288,715 | +65.2% | 11,623 | 0.0% | 0.06% | +47.7% |
| Q1 2023 | $174,810 | +27.1% | 11,623 | 0.0% | 0.04% | +18.9% |
| Q4 2022 | $137,500 | +99.3% | 11,623 | 0.0% | 0.04% | +76.2% |
| Q3 2022 | $69,000 | +40.8% | 11,623 | 0.0% | 0.02% | +40.0% |
| Q2 2022 | $49,000 | -55.9% | 11,623 | 0.0% | 0.02% | -46.4% |
| Q1 2022 | $111,000 | -49.8% | 11,623 | 0.0% | 0.03% | -46.2% |
| Q4 2021 | $221,000 | -42.9% | 11,623 | 0.0% | 0.05% | -48.0% |
| Q3 2021 | $387,000 | -14.2% | 11,623 | 0.0% | 0.10% | -16.7% |
| Q2 2021 | $451,000 | -52.5% | 11,623 | -41.0% | 0.12% | -57.4% |
| Q1 2021 | $950,000 | – | 19,700 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
| Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
| Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
| BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
| Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
| 683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
| Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
| Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |